A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

Clinical trial NCT05577715 · TERMINATED

Trial details

NCT number: NCT05577715
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2022-11-14
Primary completion: 2024-08-12
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.